please wait
 
close window

New Product Development and Material Transfer Agreements

New product development and process innovation often start within the context of established technology. Perhaps a drug is effective as a treatment for a disease but has severe and harmful side effect.

A researcher speculates that a portion of a particular plant that can be found only in a rain forest might be used to buffer the drug’s unwanted side effect. The researcher is faced with the dilemma of obtaining a specimen of the plant either through poaching the specimen or getting the plant from a legally recognized source.

Material Transfer Agreements (MTAs) are contracts that authorize the transfer of the right of possession without transfer of ownership from the owner to a user. They are an essential tool in the ownership and control of bioproperty.

MTAs are integral to realizing financial and other benefits from the ownership and control of valuable bioproperty. These agreements are a cornerstone of the life science technology industry. Understanding MTAs and their use is essential for new product development between organizations. BPSG teaches students how to make the most of their new product developments as well as create and use MTAs for both owners and users of biological materials.

The Nagoya Protocol is central to the creation and use of MTAs

The recently ratified Nagoya Protocol provides a general outline of the terms of transferring a specimen from within the confines of one geopolitical entity to another. A researcher could obtain a plant sample through legal channels under the Nagoya Protocol.

However, the Nagoya Protocol does not dictate the method that regulates the actual transfer of the specimen from the source entity to the researching entity.

Fortunately, BioProperty Strategy Group has drafted many MTAs that consistently and effectively control the transfer of physical specimens from one geopolitical entity for research purposes located inside another entity. We can teach you how to draft your own MTAs to legally and effectively transfer vital specimen samples from one country to another.

Contact BioProperty Strategy Group today by email or at (607) 229-0802 for more information concerning how you or your organization can participate in one of our upcoming Market Research and Business Planning, Technology Licensing, Geographical Indications & Certification Marks or New Product Development and Material Transfer Agreements seminars to advance your process innovation, new product development process or agribusiness.